Minimal Change Disease with Progression to Focal Segmental Glomerulosclerosis: Support for an Immune-Mediated Disease Continuum

By afschroeder • January 5, 2026

Muthyala R, Thummala AR, Neinast M, Peterson JD. Minimal Change Disease with Progression to Focal Segmental Glomerulosclerosis: Support for an Immune-Mediated Disease Continuum. J Brown Hosp Med. 2026 Jan 1;5(1):154640. doi: 10.56305/001c.154640. PMID: 41488452; PMCID: PMC12764328.

Tags: Focal segmental glomerulosclerosis, FSGS, General Internal Medicine, Hospitalist, mcd, minimal change disease, plasmapheresis, Publications, Resident

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Amaeshi L, Laufer L, Fedorov K, Sisto A, Levitz D, Mathew R, Wright K, Cooper D, Goldfinger M, Mantzaris I, Sica RA, Gritsman K, Konopleva[...]

CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming

Wang MR, Mu W, Zhen A, Kitchen SG. CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming. Trends Biotechnol. 2026 Jan 5:S0167-7799(25)00499-8.[...]

Trans-ancestry GWAS of hot flashes reveals potent treatment target and overlap with psychiatric disorders

Werwath KE, Lawn RB, Salem MT, Li T, Mitchell BL, Shen H, Gordon SD, Kung B, Stafford C, Vemuri M, Ratanatharathorn A, Meijsen J, Shadyab[...]